SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is actively trending as market participants analyze former President Trump's speech at the World Economic Forum in Davos. His remarks, particularly those concerning Greenland and the broader economic outlook, are sparking intense debate within the community. Discussion centers on whether his bullish pronouncements or controversial international rhetoric will ultimately dictate market sentiment amid geopolitical tensions.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending as Donald Trump's remarks at the World Economic Forum captivate audiences, with community attention centered on his controversial proposals for tariffs and persistent calls to acquire Greenland. These statements are fueling polarized debates regarding their potential impact on international relations and market stability, alongside widespread commentary on his public speaking style.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after an earnings report that, despite exceeding estimates, has sparked significant debate regarding subscriber growth, cautious guidance, and the strategic implications of its potential Warner Bros. Discovery acquisition. While many view the current dip as an oversold buying opportunity for a market leader, concerns around debt, a paused buyback program, and slower growth are driving a bearish outlook, with the community sharply divided on the stock's immediate future.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is trending following news that its subsidiary, Lucid Diagnostics, was awarded a contract by the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test. This development has ignited widespread community discussion, with many highlighting the stock's low share float and speculating about a potential short squeeze, drawing parallels to other recent volatile small-cap movements. Community members are actively debating the contract's impact on PAVmed's valuation, especially given its significant ownership stake in Lucid.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to widespread market discussion around geopolitical tensions, specifically former President Trump's rhetoric on Greenland and trade policy during his Davos address. The community is actively debating whether perceived softening in his stance will alleviate pressure or if broader concerns over trade relations and central bank policy will continue to influence growth-oriented tech assets.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing heightened investor attention and bullish momentum as multiple analyst upgrades and anticipation of its upcoming earnings report fuel a narrative of a strong turnaround. The community is actively discussing its resilience and upward trajectory, particularly given its performance on down market days, with many highlighting its strategic position in AI and domestic manufacturing capabilities amidst robust demand.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid an intense geopolitical spotlight on Greenland's strategic rare earth minerals, fueled by recent statements from a former President emphasizing the territory's importance for national security. The community is actively discussing significant price volatility and potential market manipulation, with many anticipating a major business update from the company as a key catalyst. This narrative positions CRML as a central player in securing a Western critical minerals supply chain, driving strong bullish sentiment among investors despite recent fluctuations.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following positive FDA guidance requiring no new trials for its ANKTIVA sBLA, with resubmission expected within 30 days, signaling a clear path for label expansion in bladder cancer. The community is highly optimistic about this de-risked pathway, alongside significant international approvals like Saudi Arabia's for NSCLC, fueling strong discussions of a potential short squeeze and the company's broader impact on cancer treatment.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5% - Time to Sell?

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 6.5% - What's Next...

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.4% - Time to Sell?

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 6.4% - Here's What Happened...

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Rating of "Moderate Buy" from Analysts

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten research firms that are covering the firm, MarketBeat reports. One...

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $2,719,986.57 in Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 75,117 shares of the firm's stock in a transaction on Tuesday, December 23rd. The stock was sold at an...

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $928,072.48 in Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 26,011 shares of the business's stock in a transaction dated Wednesday, December 24th. The shares were...

Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells 43,872 Shares of Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 43,872 shares of the firm's stock in a transaction on Friday, December 26th. The shares were sold at...

Louise Frederika Kooij Sells 75,117 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 75,117 shares of the company's stock in a transaction on Tuesday, December 23rd. The shares were sold...

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Stifel Nicolaus increased their target price on shares of NewAmsterdam Pharma from $44.00 to $50.00 and gave the company a "buy" rating in a research note on Tuesday...

Frazier Life Sciences Management L.P. Has $300.75 Million Stock Position in NewAmsterdam Pharma Company N.V. $NAMS

Frazier Life Sciences Management L.P. raised its holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 3.0% in the 2nd quarter, according to its most recent Form 13F filing with...

NewAmsterdam Pharma Company N.V. $NAMS Holdings Lifted by Maverick Capital Ltd.

Maverick Capital Ltd. raised its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 178.8% during the 2nd quarter, according to its most recent disclosure with the Securities...

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.

NewAmsterdam Pharma Company NV

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$33.23
Prev Close	$32.41
Open	$32.86
Dividend Yield	0.00%
50-Day Moving Average	$36.11
Beta	0.87
Avg. Volume	990,939.64
PE Ratio	-15.87

52-Week High	$42.00
52-Week Low	$14.06
Market Capitalization	$3.67B
EPS (Annual)	-$2.56
Price to Book	5.04
Revenue Per Employee	$670,044.12
Enterprise Value/EBITDA	N/A

NAMS
NewAmsterdam Pharma Company NV

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NAMS News

NAMSNewAmsterdam Pharma Company NV